Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1412-1423
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1412
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1412
Figure 4 Expression of cluster of differentiation 147 in hepatocellular carcinoma clinical characteristics from The Cancer Genome Atlas database.
A: Normal vs age, P < 0.05; B: Normal vs sex, P < 0.05; male vs female, P = 4.26 × 10-2; C: Normal vs tumor grade, P < 0.05; grade 1 vs grade 2, P = 2.88 × 10-2; grade 1 vs grade 3, P = 1.94 × 10-3; D: Normal vs stage, P < 0.05; stage 1 vs stage 3, P = 2.72 × 10-3; E: Normal vs weight, P < 0.05; F: Normal vsN (0 and 1), P < 0.05; G: Normal vs histological; H: Normal vs TP53 mutant, P < 1 × 10-12; normal vs TP53 nonmutant, P = 1.62 × 10-12. Normal weight: Body mass index between 18.5 and 25; Extreme weight: Body mass index between 25 and 30; Obese: Body mass index between 30 and 40; Extreme obese: Body mass index greater than 40. BSG: Basigin; TCGA: The Cancer Genome Atlas.
- Citation: Xu YJ, He HJ, Wu P, Li WB. Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(8): 1412-1423
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1412.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1412